Skip to main content
. 2024 Jul 24;48:102060. doi: 10.1016/j.tranon.2024.102060

Fig. 2.

Fig 2

RFS and OS of NAC cohort

RFS (A) and OS (B) stratified according to TP53 signature status; RFS (C) and OS (D) stratified according to pCR status and TP53 signature status.

RFS, recurrence-free survival; OS, overall survival; NAC, neoadjuvant chemotherapy; pCR, pathological complete response; wt, wild-type signature, mt, mutant signature; HR, hazard ratio; CI: confidence interval; NA, not available.